CyberOptics Corp
NASDAQ:CYBE
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
CyberOptics Corp
Cash & Cash Equivalents
CyberOptics Corp
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
CyberOptics Corp
NASDAQ:CYBE
|
Cash & Cash Equivalents
$8.9m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
KLA Corp
NASDAQ:KLAC
|
Cash & Cash Equivalents
$1.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
Applied Materials Inc
NASDAQ:AMAT
|
Cash & Cash Equivalents
$7.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
18%
|
CAGR 10-Years
11%
|
|
Entegris Inc
NASDAQ:ENTG
|
Cash & Cash Equivalents
$340.7m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-1%
|
|
Lam Research Corp
NASDAQ:LRCX
|
Cash & Cash Equivalents
$5.7B
|
CAGR 3-Years
16%
|
CAGR 5-Years
3%
|
CAGR 10-Years
16%
|
|
Teradyne Inc
NASDAQ:TER
|
Cash & Cash Equivalents
$707.4m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
12%
|
See Also
What is CyberOptics Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
8.9m
USD
Based on the financial report for Jun 30, 2022, CyberOptics Corp's Cash & Cash Equivalents amounts to 8.9m USD.
What is CyberOptics Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
4%
Over the last year, the Cash & Cash Equivalents growth was -7%. The average annual Cash & Cash Equivalents growth rates for CyberOptics Corp have been -3% over the past three years , 4% over the past five years .